Member Info for AgentB

Thank you Blownit. I have just had a message from LSE that their technical team are working to resolve the issue.

Is anyone else experiencing the same problem? No RNS for any company showing on LSE today...or is it just me?

I think people on this board should be lenient with newbies making this mistake. It took me about 5 weeks to spot it. As an English graduate, I thought ‘Affirmer’ was a brilliant name for a diagnostic platform. Now that I know it’s ‘Affimer’, I want to know whether there is a scientific rationale for this spelling or whether it might have been a simple mistake somewhere along the line?

I also love ‘PreCISION’ - which I am taking quite literally as meaning ‘before cutting’ (so ‘sparing the surgery,). What a wonderful thought and a wonderful company.

GLA

Combination of bad PR for the Heathrow ‘Bigfoot’ test and increasing mentions of the Avacta name in the media (Talksport radio today and Peston’s Twitter account a few days ago), it’s going to rocket very soon!

That’s more like it!

What does ‘a log way off’ mean? I guess they say: “A week is a long time in politics!”

Between Boris’s timescales and Sir Al’s lies the truth. Patience and good luck to all!

“The credentials of the technology are further muddied by apparent connections to an organisation that spent decades working on hoaxes about the fictional monster Big Foot.

Lord Global Corporation, formerly called Bigfoot Projects Inc, is financing the distribution of Virolens machines in Australia, Latin America and south-east Asia....”

They really sound like snake oil salesmen!

Speaking of batteries, a small Canadian company called Nano One technologies has started trading on LSE On 11th Sept with ticker 0T6N. I am not cross-ramping because I don’t own it. I am just curious. Apparently it has the IP to multiply the lifespan of lithium batteries. VW has an interest. https://www.electrive.com/2019/06/22/battery-developer-nano-one-awarded-contract-from-carmaker/. I did own shares via the Canadian Stock exchange but sold them in favour of Covid stocks. As yet there seems to be no trading of the stock in the U.K. and no discussion on the board, so I thought I would plant a seed. I may return to it before Tesla battery day. ;-)

Kitty, Sorry, I meant $140. It goes into auction at $100 to $120 but will probs come out somewhat higher. Question is how much higher?

I have a limit order in with AJ Bell, but they can only trade after the IPO auction is finished. My limit is $1.40. Do you think I’ll get any?

Sadly, he’s not as good for our SP as Matt Han****

https://www.parliamentlive.tv/Event/Index/ea4c881b-8f95-4b06-857e-f6b20478f2ad

Boris under fire from Angela Rayner on testing/care homes and lack of plan.

You’ve got to admire their ‘celeb’ endorsement marketing strategy. Works a treat with their target demographic.

One with and one without detection of flu?

Maybe we’ll get the good news sooner then? I wonder how much longer the martyrdom of Matt Han**** can go on for...

PL and GAZALA you have both excelled yourselves in this thread ;-)

There is an Integumen ‘investormeetcompany‘ event this morning to discuss MWG merger. I note that there is no possibility to submit questions. Perhaps there was a worry that Gerard Brandon might give something away that’s Moonshot related! There is definitely an air of secrecy across these three companies that are using affimer technology in relation to COVID.

OK, thanks Mowze and thanks to Hants too.

“Importantly, since this test indicates an immune response to current, or recent infection, it can alert users if they should immediately self-isolate to stop the spread of the disease.“

I didn’t realise that antibody tests could identify ‘current’ infection. Do the scientists on here believe this claim, or is it marketing hype?

Yes. Ours are better!

Affimer reagents have key benefits compared with antibodies as virus neutralising therapies: Their small size and high solubility means that a much higher concentration of Affimer molecules can be used in the drug formulation to more effectively block the spike proteins on each virus particle and better protect the patient; bispecific and trispecific Affimer neutralising therapies that bind to more than one part of the spike protein could ensure the effectiveness of the neutralising therapy even if the virus' spike protein mutates.

Poor old Sir Al, he must be nearly exhausted by now! I’m exhausted just thinking about all the plates he’s spinning. He’ll deffo deserve a knighthood at the end of all this.